Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
European operations' revenue grew 58.4% to Rs 599.7 crore
US business grew by +12.8% YoY
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Advances Amgen's mission to serve patients with rare disease medicines
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)